Skip to main content
Erschienen in: Archives of Virology 1/2020

19.10.2019 | Original Article

Hepatitis viruses take advantage of traditional practices to increase the burden of hepatocellular carcinoma in Tunisia

verfasst von: Ines Dhifallah, Marwa Khedhiri, Anissa Chouikha, Ghassen Kharroubi, Walid Hammami, Amel Sadraoui, Mohamed Msaddek Azzouz, Nadia Maamouri, Tahar Khalfallah, Henda Triki, Pascal Pineau, Olfa Bahri

Erschienen in: Archives of Virology | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Abstract

Hepatocellular carcinoma (HCC) is a major public health issue in Africa. In Tunisia, hepatitis B virus (HBV) is known to be an important risk factor for HCC in the south of the country, but the role played by hepatitis C virus (HCV) still remains unclear. The aim of the current case-control study was to identify risk factors for HCC development in the northern part of the country. Clinical and biological data including viral hepatitis status (serological and molecular) and non-infectious risk factors from 73 patients with HCC and 70 control subjects without hepatic diseases were collected. The mean age of the patients was 63 ± 10 years, and the ratio of males to females was 1.1. HCC occurred in cirrhotic liver in 72.0% of the cases. HCV infection was the dominant risk factor (64.3% of cases); the presence of HBV was observed in 53.4% of the cases. Occult hepatitis B and C were implicated, respectively, in 30.1% and 9.6% of the cases. HCV genotype 1b was predominant. Patients originating from western Tunisia formed a homogeneous group, characterized by significantly higher rates of tattoos or scarifications (83%) and HCV infection (80%) than those from other parts of the country. Chronic HCV infection is currently the primary risk factor for HCC in Tunisia; HBV infection remains frequent in its overt or occult infection forms. Traditional esthetic practices apparently contribute to increasing the burden of terminal liver diseases in western Tunisia.
Literatur
1.
Zurück zum Zitat Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893–2917PubMed Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893–2917PubMed
2.
Zurück zum Zitat Mittal S, El-Serag HB (2013) Epidemiology of hepatocellular carcinoma: consider the population. J Clin Gastroenterol 47:S2–S6PubMedPubMedCentral Mittal S, El-Serag HB (2013) Epidemiology of hepatocellular carcinoma: consider the population. J Clin Gastroenterol 47:S2–S6PubMedPubMedCentral
3.
Zurück zum Zitat Levero M (2006) Viral hepatitis and liver cancer: the case of hepatitis C. Oncogene 25:3834–3847 Levero M (2006) Viral hepatitis and liver cancer: the case of hepatitis C. Oncogene 25:3834–3847
4.
Zurück zum Zitat Venook AP, Papandreou C, Furuse J, de Guevara LL (2010) The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. Oncologist 4:5–13 Venook AP, Papandreou C, Furuse J, de Guevara LL (2010) The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. Oncologist 4:5–13
5.
Zurück zum Zitat Güthle M, Dollinger MM (2014) Epidemiology and risk factors of hepatocellular carcinoma. Radiologe 54:654–659PubMed Güthle M, Dollinger MM (2014) Epidemiology and risk factors of hepatocellular carcinoma. Radiologe 54:654–659PubMed
6.
Zurück zum Zitat Allain JP (2005) Occult hepatitis B virus infection. Hep B Annual 2:14–30 Allain JP (2005) Occult hepatitis B virus infection. Hep B Annual 2:14–30
7.
Zurück zum Zitat DeMitri MS, Cassini R, Bernardi M (2010) Hepatitis B virus-related hepatocarcinogenesis: molecular oncogenic potential of clear or occult infections. Eur J Cancer 46:2178–2186 DeMitri MS, Cassini R, Bernardi M (2010) Hepatitis B virus-related hepatocarcinogenesis: molecular oncogenic potential of clear or occult infections. Eur J Cancer 46:2178–2186
8.
Zurück zum Zitat Morales-Romero J, Vargas G, García-Román R (2014) Occult HBV infection: a facelessenemy in liver cancer development. Viruses 8:1590–1611 Morales-Romero J, Vargas G, García-Román R (2014) Occult HBV infection: a facelessenemy in liver cancer development. Viruses 8:1590–1611
9.
Zurück zum Zitat Registre des cancers Nord-Tunisie 1993–2003. Institut national de la santé publique. Ministère de la santé publique Registre des cancers Nord-Tunisie 1993–2003. Institut national de la santé publique. Ministère de la santé publique
10.
Zurück zum Zitat Salim EI, Moore MA, Al-Lawati JA, Al-Sayyad J, Bazawir A, Bener A et al (2009) Cancer epidemiology and control in the Arab World- past, present and future. Asian Pac J Cancer Prev 10:3–16PubMed Salim EI, Moore MA, Al-Lawati JA, Al-Sayyad J, Bazawir A, Bener A et al (2009) Cancer epidemiology and control in the Arab World- past, present and future. Asian Pac J Cancer Prev 10:3–16PubMed
11.
Zurück zum Zitat Bahri O, Ezzikouri S, Alaya-Bouafif NB, Iguer F, Feydi AE, Mestiri H et al (2011) First multicenter study for risk factors for hepatocellular carcinoma development in North Africa. World J Hepatol 27:24 Bahri O, Ezzikouri S, Alaya-Bouafif NB, Iguer F, Feydi AE, Mestiri H et al (2011) First multicenter study for risk factors for hepatocellular carcinoma development in North Africa. World J Hepatol 27:24
12.
Zurück zum Zitat Said Y, Debbeche R, Ben Ali Z, Bouzid K, Trabelsi S, Bouzaidi S et al (2012) Epidemiological, clinical and therapeutic features of hepatocellular carcinoma in cirrhotic patients. Tunis Med 90:468–472PubMed Said Y, Debbeche R, Ben Ali Z, Bouzid K, Trabelsi S, Bouzaidi S et al (2012) Epidemiological, clinical and therapeutic features of hepatocellular carcinoma in cirrhotic patients. Tunis Med 90:468–472PubMed
13.
Zurück zum Zitat Hefaiedh R, Elloumi H, Ouakaa A, Elloumi H, Kochlef A, Gargouri D et al (2009) Management of the hepatocellular carcinoma. Tunis Med 87:721–725PubMed Hefaiedh R, Elloumi H, Ouakaa A, Elloumi H, Kochlef A, Gargouri D et al (2009) Management of the hepatocellular carcinoma. Tunis Med 87:721–725PubMed
14.
Zurück zum Zitat Triki H (1994) Epidemiology of hepatitis B virus, hepatitis C virus and Delta virus in the general population and in liver cirrhosis in Tunisia. Arch Inst Pasteur Tunis 71:403PubMed Triki H (1994) Epidemiology of hepatitis B virus, hepatitis C virus and Delta virus in the general population and in liver cirrhosis in Tunisia. Arch Inst Pasteur Tunis 71:403PubMed
15.
Zurück zum Zitat Rajhi M, Mejri S, Djebbi A, Chouaieb S, Cheikh I, Ben Yahia A et al (2014) Subtyping genotype 2 hepatitis C viruses from Tunisia: identification of two putative new subtypes. Virus Genes 48:209–217PubMed Rajhi M, Mejri S, Djebbi A, Chouaieb S, Cheikh I, Ben Yahia A et al (2014) Subtyping genotype 2 hepatitis C viruses from Tunisia: identification of two putative new subtypes. Virus Genes 48:209–217PubMed
16.
Zurück zum Zitat Sibnarayan D et al (2008) Analysis of hepatitis B virus X gene phylogeny, genetic variability and its impact on pathogenesis: implications in Eastern Indian HBV carriers. Virology 382(2):190–198 Sibnarayan D et al (2008) Analysis of hepatitis B virus X gene phylogeny, genetic variability and its impact on pathogenesis: implications in Eastern Indian HBV carriers. Virology 382(2):190–198
17.
Zurück zum Zitat Chemin I, Zoulim F, Merle P, Arkhis A, Chevallier M, Kay A et al (2001) High incidence of hepatitis B infections among chronic hepatitis cases of unknown a etiology. J Hepatol 31:447–454 Chemin I, Zoulim F, Merle P, Arkhis A, Chevallier M, Kay A et al (2001) High incidence of hepatitis B infections among chronic hepatitis cases of unknown a etiology. J Hepatol 31:447–454
18.
Zurück zum Zitat Kew M (2013) Epidemiology of hepatocellular carcinoma in sub-Saharan Africa. Ann Hepatol 12:173–182PubMed Kew M (2013) Epidemiology of hepatocellular carcinoma in sub-Saharan Africa. Ann Hepatol 12:173–182PubMed
19.
Zurück zum Zitat Dogan E, Yalcin S, Koca D, Olmez A (2012) Clinicopathological characteristics of hepatocellular carcinoma in Turkey. Asian Pac J Cancer Prev 13:2985–2990PubMed Dogan E, Yalcin S, Koca D, Olmez A (2012) Clinicopathological characteristics of hepatocellular carcinoma in Turkey. Asian Pac J Cancer Prev 13:2985–2990PubMed
20.
Zurück zum Zitat Miquel M, Sopeña J, Vergara M, Gil M, Casas M, Sánchez-Delgado J et al (2012) Factors related to survival in hepatocellular carcinoma in the geographic area of Sabadell (Catalonia, Spain). Rev Esp Enferm Dig 1:242 Miquel M, Sopeña J, Vergara M, Gil M, Casas M, Sánchez-Delgado J et al (2012) Factors related to survival in hepatocellular carcinoma in the geographic area of Sabadell (Catalonia, Spain). Rev Esp Enferm Dig 1:242
21.
Zurück zum Zitat Appel-da-Silva MC, da Silva Miozzo SA, de Azevedo DI, Tovo CV, Branco F, de Mattos AA (2016) Incidence of hepatocellular carcinoma in outpatients with cirrhosis in Brazil: a 10-year retrospective cohort study. World J Gastroenterol 14:10219 Appel-da-Silva MC, da Silva Miozzo SA, de Azevedo DI, Tovo CV, Branco F, de Mattos AA (2016) Incidence of hepatocellular carcinoma in outpatients with cirrhosis in Brazil: a 10-year retrospective cohort study. World J Gastroenterol 14:10219
22.
Zurück zum Zitat Norredam K (1977) Primary carcinoma of the liver in Malawi: a review of 24 cases. Trop Geogr Med 29:141–149PubMed Norredam K (1977) Primary carcinoma of the liver in Malawi: a review of 24 cases. Trop Geogr Med 29:141–149PubMed
23.
Zurück zum Zitat Diop B, Denis F, Barin F (1981) Epidemiology of primary hepatocellular carcinoma in Senegal. Progress in medical virology. Fortschritte der medizinischen Virusforschung. Prog Med Virol 27:35–40PubMed Diop B, Denis F, Barin F (1981) Epidemiology of primary hepatocellular carcinoma in Senegal. Progress in medical virology. Fortschritte der medizinischen Virusforschung. Prog Med Virol 27:35–40PubMed
24.
Zurück zum Zitat Kashala LO, Kalengayi MM, Conne B, Kapanci Y, Frei PC, Lambert PH (1990) Histopathologic features of hepatocellular carcinoma in Zaire. Cancer 65:130–134PubMed Kashala LO, Kalengayi MM, Conne B, Kapanci Y, Frei PC, Lambert PH (1990) Histopathologic features of hepatocellular carcinoma in Zaire. Cancer 65:130–134PubMed
25.
Zurück zum Zitat Alavian SM, Haghbin H (2016) Relative importance of hepatitis B and C viruses in hepatocellular carcinoma in EMRO countries and the Middle East: a systematic review. Hepat Mon 16(3):e35106PubMedPubMedCentral Alavian SM, Haghbin H (2016) Relative importance of hepatitis B and C viruses in hepatocellular carcinoma in EMRO countries and the Middle East: a systematic review. Hepat Mon 16(3):e35106PubMedPubMedCentral
26.
Zurück zum Zitat Huang YT, Jen CL, Yang HI, Lee MH, Su J, Lu SN et al (2011) Lifetime risk and sex difference of hepatocellular carcinoma among patients with chronic hepatitis B and C. J Clin Oncol 29:3643–3650PubMedPubMedCentral Huang YT, Jen CL, Yang HI, Lee MH, Su J, Lu SN et al (2011) Lifetime risk and sex difference of hepatocellular carcinoma among patients with chronic hepatitis B and C. J Clin Oncol 29:3643–3650PubMedPubMedCentral
27.
Zurück zum Zitat Bosch FX, Ribes J, Borras J (1999) Epidemiology of primary liver cancer. Semin Liver Dis 19:271–285PubMed Bosch FX, Ribes J, Borras J (1999) Epidemiology of primary liver cancer. Semin Liver Dis 19:271–285PubMed
28.
Zurück zum Zitat El Serag HB (2002) Hepatocellular carcinoma and hepatitis C in the United States. Hepatology 36:S74–S83PubMed El Serag HB (2002) Hepatocellular carcinoma and hepatitis C in the United States. Hepatology 36:S74–S83PubMed
29.
Zurück zum Zitat Hassan MM, Frome A, Patt YZ (2002) EL-Serag HB: rising prevalence of hepatitis C virus infection among patients recently diagnosed with hepatocellular carcinoma in the United States. J Clin Gastroenterol 35:266–299PubMed Hassan MM, Frome A, Patt YZ (2002) EL-Serag HB: rising prevalence of hepatitis C virus infection among patients recently diagnosed with hepatocellular carcinoma in the United States. J Clin Gastroenterol 35:266–299PubMed
30.
Zurück zum Zitat Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP (2006) The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 45:529–538PubMed Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP (2006) The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 45:529–538PubMed
31.
Zurück zum Zitat Okuda K, Fujimoto I, Hanai A, Urano Y (1987) Changing incidence of hepatocellular carcinoma in Japan. Cancer Res 47:4967–4972PubMed Okuda K, Fujimoto I, Hanai A, Urano Y (1987) Changing incidence of hepatocellular carcinoma in Japan. Cancer Res 47:4967–4972PubMed
32.
Zurück zum Zitat Deuffic S, Buffat L, Poynard T, Valleron AJ (1999) Modeling the hepatitis C virus epidemic in France. Hepatology 29:1596–1601PubMed Deuffic S, Buffat L, Poynard T, Valleron AJ (1999) Modeling the hepatitis C virus epidemic in France. Hepatology 29:1596–1601PubMed
33.
Zurück zum Zitat Law MG (1999) Modeling the hepatitis C virus epidemic in Australia hepatitis C Virus Projections Working Group. J Gastroenterol Hepatol 14:1100–1107PubMed Law MG (1999) Modeling the hepatitis C virus epidemic in Australia hepatitis C Virus Projections Working Group. J Gastroenterol Hepatol 14:1100–1107PubMed
34.
Zurück zum Zitat Erhardt A, Theobald I, Petry W, Röhrborn A, Heintges T, Wettstein M et al (2002) Hepatozelluläres Karzinom. Dtsch Med Wochenschr 127:2665–2668PubMed Erhardt A, Theobald I, Petry W, Röhrborn A, Heintges T, Wettstein M et al (2002) Hepatozelluläres Karzinom. Dtsch Med Wochenschr 127:2665–2668PubMed
35.
Zurück zum Zitat Davila JA, Morgan RO, Shaib Y, McGlynn KA, El-Serag HB (2004) Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study. Gastroenterology 127:1372–1380PubMed Davila JA, Morgan RO, Shaib Y, McGlynn KA, El-Serag HB (2004) Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study. Gastroenterology 127:1372–1380PubMed
36.
Zurück zum Zitat El-Zayadi AR, Badran HM, Barakat EM, Attia Mel D, Shawky S, Mohamed MK et al (2005) Hepatocellular carcinoma in Egypt: a single center study over a decade. World J Gastroenterol 11:5193PubMedPubMedCentral El-Zayadi AR, Badran HM, Barakat EM, Attia Mel D, Shawky S, Mohamed MK et al (2005) Hepatocellular carcinoma in Egypt: a single center study over a decade. World J Gastroenterol 11:5193PubMedPubMedCentral
37.
Zurück zum Zitat Hajarizadeh B, Grebely J, Dore GJ (2013) Epidemiology and natural history of HCV infection. Nature reviews. Nat Rev Gastroenterol Hepatol 10:553–562PubMed Hajarizadeh B, Grebely J, Dore GJ (2013) Epidemiology and natural history of HCV infection. Nature reviews. Nat Rev Gastroenterol Hepatol 10:553–562PubMed
38.
Zurück zum Zitat Kirk GD, Lesi OA, Mendy M, Akano AO, Sam O, Goedert JJ et al (2004) The Gambia Liver Cancer Study: infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa. Hepatology 39:211–219PubMed Kirk GD, Lesi OA, Mendy M, Akano AO, Sam O, Goedert JJ et al (2004) The Gambia Liver Cancer Study: infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa. Hepatology 39:211–219PubMed
39.
Zurück zum Zitat Gao JD, Shao YF, Xu Y, Ming LH, Wu ZY, Liu GT et al (2005) Tight association of hepatocellular carcinoma with HBV infection in North China. Hepatobiliary Pancreat Dis Int 4:46–49PubMed Gao JD, Shao YF, Xu Y, Ming LH, Wu ZY, Liu GT et al (2005) Tight association of hepatocellular carcinoma with HBV infection in North China. Hepatobiliary Pancreat Dis Int 4:46–49PubMed
40.
Zurück zum Zitat Uzunalimoglu O, Yurdaydin C, Cetinkaya H, Bozkaya H, Sahin T (2001) Risk factors for hepatocellular carcinoma in Turkey. Dig Dis Sci 46:1022–1028PubMed Uzunalimoglu O, Yurdaydin C, Cetinkaya H, Bozkaya H, Sahin T (2001) Risk factors for hepatocellular carcinoma in Turkey. Dig Dis Sci 46:1022–1028PubMed
41.
Zurück zum Zitat Yaghi C, Sharara A, Rassam P, Moucari R, Honein K, BouJaoude J et al (2006) Hepatocellular carcinoma in Lebanon: etiology and prognostic factors associated with short-term survival. World J Gastroenterol 12:3575PubMedPubMedCentral Yaghi C, Sharara A, Rassam P, Moucari R, Honein K, BouJaoude J et al (2006) Hepatocellular carcinoma in Lebanon: etiology and prognostic factors associated with short-term survival. World J Gastroenterol 12:3575PubMedPubMedCentral
42.
Zurück zum Zitat Kremsdor FD, Soussan P, Paterlini-Brechot P, Brechot C (2006) Hepatitis B virus-related hepatocellular carcinoma: paradigms for viral-related human carcinogenesis.Oncogene 25:3823–3833PubMed Kremsdor FD, Soussan P, Paterlini-Brechot P, Brechot C (2006) Hepatitis B virus-related hepatocellular carcinoma: paradigms for viral-related human carcinogenesis.Oncogene 25:3823–3833PubMed
43.
Zurück zum Zitat Hayashi J, Aoki H, Arakawa Y, Hino O (1999) Hepatitis C virus and hepatocarcinogenesis. Intervirology 42:205–210PubMed Hayashi J, Aoki H, Arakawa Y, Hino O (1999) Hepatitis C virus and hepatocarcinogenesis. Intervirology 42:205–210PubMed
44.
Zurück zum Zitat Pineau P, Ezzikouri S, Marchio A, Benazzouz M, Cordina E, Afifi R et al (2007) Genomic stability prevails in North-African hepatocellular carcinomas. Dig Liver Dis 39:671–677PubMed Pineau P, Ezzikouri S, Marchio A, Benazzouz M, Cordina E, Afifi R et al (2007) Genomic stability prevails in North-African hepatocellular carcinomas. Dig Liver Dis 39:671–677PubMed
45.
Zurück zum Zitat Shawki SM, Meshaal SS, El Dash AS, Zayed NA, Hanna MO (2014) Increased DNA damage in hepatitis C virus-related hepatocellular carcinoma. DNA Cell Biol 33:884–890PubMed Shawki SM, Meshaal SS, El Dash AS, Zayed NA, Hanna MO (2014) Increased DNA damage in hepatitis C virus-related hepatocellular carcinoma. DNA Cell Biol 33:884–890PubMed
46.
Zurück zum Zitat Ali A, Abdel-Hafiz H, Suhail M, Suhail M, Al-Mars A, Zakaria MK et al (2014) Hepatitis B virus, HBx mutants and their role in hepatocellular carcinoma. World J Gastroenterol 20:10238PubMedPubMedCentral Ali A, Abdel-Hafiz H, Suhail M, Suhail M, Al-Mars A, Zakaria MK et al (2014) Hepatitis B virus, HBx mutants and their role in hepatocellular carcinoma. World J Gastroenterol 20:10238PubMedPubMedCentral
47.
Zurück zum Zitat Raimondo G, Locarnini S, Pollicino T, Levrero M, Zoulim F, Lok AS (2019) Update of the statements on biology and clinical impact of occulthepatitis b virus infection. J Hepatol 71:371–397 Raimondo G, Locarnini S, Pollicino T, Levrero M, Zoulim F, Lok AS (2019) Update of the statements on biology and clinical impact of occulthepatitis b virus infection. J Hepatol 71:371–397
48.
Zurück zum Zitat Squadrito G, Cacciola I, Alibrandi A, Pollicino T, Raimondo G (2013) Impact of occult hepatitis B virus infection on the outcome of chronic hepatitis C. J Hepatol 59:696–700PubMed Squadrito G, Cacciola I, Alibrandi A, Pollicino T, Raimondo G (2013) Impact of occult hepatitis B virus infection on the outcome of chronic hepatitis C. J Hepatol 59:696–700PubMed
49.
Zurück zum Zitat Pollicino T, Saitta C (2014) Occult hepatitis B virus and hepatocellular carcinoma. World J Gastroenterol 20:5951–5961PubMedPubMedCentral Pollicino T, Saitta C (2014) Occult hepatitis B virus and hepatocellular carcinoma. World J Gastroenterol 20:5951–5961PubMedPubMedCentral
50.
Zurück zum Zitat Bensalem A et al (2016) Eastern region represents a worrying cluster of active hepatitis C in Algeria in 2012. J Med Virol 88(8):1394–1403PubMed Bensalem A et al (2016) Eastern region represents a worrying cluster of active hepatitis C in Algeria in 2012. J Med Virol 88(8):1394–1403PubMed
51.
Zurück zum Zitat Azzalini L, Ferrer E, Ramalho LN, Moreno M, Dominguez M, Colmenero J et al (2010) Cigarette smoking exacerbates nonalcoholic fatty liver disease in obese rats. Hepatology 51:1567–1576PubMed Azzalini L, Ferrer E, Ramalho LN, Moreno M, Dominguez M, Colmenero J et al (2010) Cigarette smoking exacerbates nonalcoholic fatty liver disease in obese rats. Hepatology 51:1567–1576PubMed
52.
Zurück zum Zitat Altamirano J, Bataller R (2010) Cigarette smoking and chronic liver diseases. Gut 59:1159–1162PubMed Altamirano J, Bataller R (2010) Cigarette smoking and chronic liver diseases. Gut 59:1159–1162PubMed
53.
Zurück zum Zitat Can A, Dogan E, Bayoglu IV, Tatli AM, Besiroglu M, Kocer M et al (2014) Multicenter epidemiologic study on hepatocellular carcinoma in Turkey. Asian Pac J Cancer Prev 15:2923–2927PubMed Can A, Dogan E, Bayoglu IV, Tatli AM, Besiroglu M, Kocer M et al (2014) Multicenter epidemiologic study on hepatocellular carcinoma in Turkey. Asian Pac J Cancer Prev 15:2923–2927PubMed
54.
Zurück zum Zitat Ohishi W, Fujiwara S, Cologne JB, Suzuki G, Akahoshi M, Nishi N et al (2008) Risk factors for hepatocellular carcinoma in a Japanese population: a nested case-control study. Cancer Epidemiol Biomarkers Prev 17:846–854PubMed Ohishi W, Fujiwara S, Cologne JB, Suzuki G, Akahoshi M, Nishi N et al (2008) Risk factors for hepatocellular carcinoma in a Japanese population: a nested case-control study. Cancer Epidemiol Biomarkers Prev 17:846–854PubMed
55.
Zurück zum Zitat Davila JA, Morgan RO, Shaib Y, McGlynn KA, El-Serag HB (2005) Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study. Gut 54:533–539PubMedPubMedCentral Davila JA, Morgan RO, Shaib Y, McGlynn KA, El-Serag HB (2005) Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study. Gut 54:533–539PubMedPubMedCentral
56.
Zurück zum Zitat Arora A, Kumar A (2014) Treatment response evaluation and follow-up in hepatocellular carcinoma. J Clin Exp Hepatol 4:S126–S129PubMedPubMedCentral Arora A, Kumar A (2014) Treatment response evaluation and follow-up in hepatocellular carcinoma. J Clin Exp Hepatol 4:S126–S129PubMedPubMedCentral
57.
Zurück zum Zitat Liu C, Xiao GQ, Yan LN, Li B, Jiang L, Wen TF et al (2013) Value of α-fetoprotein in association with clinic pathological features of hepatocellular carcinoma. World J Gastroenterol 19:1811–1819PubMedPubMedCentral Liu C, Xiao GQ, Yan LN, Li B, Jiang L, Wen TF et al (2013) Value of α-fetoprotein in association with clinic pathological features of hepatocellular carcinoma. World J Gastroenterol 19:1811–1819PubMedPubMedCentral
58.
Zurück zum Zitat Qari YA, Mosli MH (2017) Epidemiology and clinical features of patients with hepatocellular carcinoma at a tertiary hospital in Jeddah. Niger J Clin Pract 20:43–47PubMed Qari YA, Mosli MH (2017) Epidemiology and clinical features of patients with hepatocellular carcinoma at a tertiary hospital in Jeddah. Niger J Clin Pract 20:43–47PubMed
59.
Zurück zum Zitat Saffroy R, Pham P, Reffas M, Takka M, Lemoine A, Debuire B (2007) New perspectives and strategy research biomarkers for hepatocellular carcinoma. Clin Chem Lab Med 45:1169–1179PubMed Saffroy R, Pham P, Reffas M, Takka M, Lemoine A, Debuire B (2007) New perspectives and strategy research biomarkers for hepatocellular carcinoma. Clin Chem Lab Med 45:1169–1179PubMed
60.
Zurück zum Zitat Giannini EG, Cucchetti A, Erroi V, Garuti F, Odaldi F, Trevisani F (2013) Surveillance for early diagnosis of hepatocellular carcinoma: how best to do it. World J Gastroenterol 19:8808–8821PubMedPubMedCentral Giannini EG, Cucchetti A, Erroi V, Garuti F, Odaldi F, Trevisani F (2013) Surveillance for early diagnosis of hepatocellular carcinoma: how best to do it. World J Gastroenterol 19:8808–8821PubMedPubMedCentral
Metadaten
Titel
Hepatitis viruses take advantage of traditional practices to increase the burden of hepatocellular carcinoma in Tunisia
verfasst von
Ines Dhifallah
Marwa Khedhiri
Anissa Chouikha
Ghassen Kharroubi
Walid Hammami
Amel Sadraoui
Mohamed Msaddek Azzouz
Nadia Maamouri
Tahar Khalfallah
Henda Triki
Pascal Pineau
Olfa Bahri
Publikationsdatum
19.10.2019
Verlag
Springer Vienna
Erschienen in
Archives of Virology / Ausgabe 1/2020
Print ISSN: 0304-8608
Elektronische ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-019-04440-5

Weitere Artikel der Ausgabe 1/2020

Archives of Virology 1/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.